Please complete the CAPTCHA to continue
@lagrayfinance.com
✓
2 phones found area 773
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Dr. Alexandra E. Graham is listed as President @ LaGray | Innovator and Co-founder at Avril Biopharma, Inc., based in Chicago, Illinois, United States. AeroLeads shows a work email signal at lagrayfinance.com, phone signal with area code 773, and a matched LinkedIn profile for Dr. Alexandra E. Graham.
Dr. Alexandra E. Graham previously worked as Vice President at Africa Ecogrowth Investment Services (Aegis) and Advisory Board Member at Avril Biopharma, Inc.. Dr. Alexandra E. Graham holds Doctor Of Philosophy (Ph.D.), Organic Chemistry from University Of Lagos.
This section adds company-level context without repeating Dr. Alexandra E. Graham's masked contact details.
AeroLeads found 1 current-domain work email signal for Dr. Alexandra E. Graham. Compare company email patterns before reaching out.
Innovative pharmaceutical and finance executive, global health advocate, and science diplomat with over three decades of experience across global health, pharmaceuticals, education, finance, and healthcare infrastructure development.My career has spanned high-profile roles in both the private and public sectors, allowing me to address complex challenges in making quality health products accessible to underserved communities. From founding West Africa’s first vertically integrated pharmaceutical manufacturing company at LaGray Chemical Company, to advancing HIV prevention initiatives at USAID, I have dedicated my expertise to advancing health equity and building sustainable healthcare systems.I am a collaborative leader skilled in strategic partnership development, policy influence, and navigating resource-constrained environments. My contributions have supported organizations like Abbott Laboratories, St. Karol School of Nursing, and the Smithsonian’s Outbreak Exhibit, always driven by the mission to improve healthcare access and quality.As a lifelong learner, I had the privilege to serve as a Science and Technology Policy Fellow at USAID, where I gained valuable insights into science diplomacy, U.S. government relations, and policy development. In my recent transition, I continue to consult in healthcare financing, helping clients access innovative funding solutions as they navigate their growth trajectories.I am excited about future opportunities to leverage my experience and passion for global health in impactful roles that bridge healthcare, policy, and sustainable business solutions.
Listed skills include Pharmaceutical Industry, Technology Transfer, Validation, Pharmaceutics, and 52 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Africa EcoGrowth Investment and Services (AEGIS) is a firm dedicated to supporting institutions, private companies and multinational corporations in their African expansion success.
Chicago, Illinois, Us
Innovator and co-founder of LaGray, an Illinois corporation focused on technological solutions toAfrica’s healthcare problems. Directed investment portfolio of holding company. Served on the Boards of Directors and ensured consistency in organizational values. Fostered productive investor relations. Successfully located and developed collaborations with multinational companies and multi-lateral development organizations. Recognized for social entrepreneurship in resource constrained environments by Massachusetts Institute of Technology Legatum Center forDevelopment and Entrepreneurship: Notable Achievements:• Established successful subsidiaries in Ghana and Nigeria; drove multi-functional teams to conduct financial feasibility, market, and environmental impact studies.• Supervised design and construction of the Ghana subsidiary, the first fully-integrated pharmaceutical manufacturing company in West Africa.• Raised and effectively allocated $4.9M loan from the United States Overseas Private Investment Corporation (OPIC) for completion of Phase I of the Ghana project.• Established held prominent roles in other subsidiaries, including the following significant leadership roles:- La Gram Chemicals, Abuja, Nigeria, Chief Executive: Ensure access to essential medicines. - Bayelsa LaGray Chemicals, PLC, Yenagoa, Nigeria; Chief Executive Lead establishment of public-private partnership between LaGray and the Bayelsa State Government in Nigeria for construction of a state-of-the-art pharmaceutical company.
St. Karol is a private university, affiliated to Kwame Nkrumah University of Science & Technology (KNUST), Ghana offering a Bachelor of Science degree in nursing to students in West Africa. Served as President and currently, a member of the governing council. Maintained affiliations and relationships with KNUST and teaching hospitals in Ghana to ensure their support and advance the school’s aims. Notable Achievements - Expanded the school’s size from 4 students to 336 students in seven years.- Successfully led 3 sets of students to graduation: 23 in 2014, with 3 in First class (Summa cum laude), 48 students in 2015, with 13 in First Class and 39 students in 2016 with 5 in First Class.
Washington, District Of Columbia, Us
Since late 2015, the US Administration has been working in countries in Latin America and the Caribbean (LAC) to combat the Zika virus, which is primarily spread through the bite of an infected Aedes mosquito and has been determined to cause birth defects including microcephaly and other neurological diseases.• Served as an expert advisor and technical authority on complex and precedent-setting policy and program issues in monitoring and evaluation (M&E) of the Zika emergency program including M&E framework revision and reporting guidelines in order to capture key outcomes/impact of the USAID Zika Response and sustainability of interventions at the end of the program in 2019.• Worked with Zika Team at Headquarters, in collaboration with the Latin America & Caribbean Bureau Health Staff and inter-Agency staff to review and map regular monitoring and evaluation reports from all mechanisms and to assess and ensure completeness of data and research documentation across themes (geographic, demographic, intervention type, etc.)• Liaised with the Ebola Team to glean lessons learned from the USAID intervention in the West Africa Ebola crisis of 2014, with the Center for Impact and Innovation (CII) to assess progress/impact of Zika Grand Challenges portfolio and with the Office of Policy, Programs and Planning to ensure adherence to USAID policy guidelines on monitoring and evaluation.• Redesigned data collection, management, and use guidelines for team members to identify lessons learned and for dissemination of key findings into communications products, fact sheets, data visualizations, evaluations and future research activities.• Negotiated information needs and reporting formats with all key stakeholders
Washington, District Of Columbia, Us
The Office of HIV AIDS (OHA) at USAID Bureau for Global Health is an Implementing Agency of the President's Emergency Plan for AIDS Relief (PEPFAR), managed by the Office of the Global AIDS Coordinator at the State Department (S/GAC).My primary role at OHA was as a Technical Expert supporting the development and market introduction of innovative methods of HIV prevention in women including vaginal rings, patches, long-acting injectables and oral pre-exposure prophylactics (PrEP). In this role, I provided guidance on program strategy; reviewed work plans and budgets, participated in organizing the annual project advisory committee and cooperating agencies meetings for implementing partners and participated in technical working groups and meetings with other USG agencies and partners.Notable Achievements: Recognized with AAAS Fellowship Award for launching an innovative project, focused on strategically reducing the time to registration and supply of HIV prevention and treatment products in Sub-Saharan Africa. Selected form dozens of qualified experts to represent USAID on an interagency Epidemic Control Leadership Team (ECT) hosted by S/GAC to support the PEPFAR Strategy for Accelerating HIV/AIDS Epidemic Control (2017 – 2020) Played a key role as key technical resource in ECT for HIV prevention technologies, oral pre-exposure prophylaxis (PrEP), adolescent girls and young women (AGYW), public-private partnerships, costing/finance and sustainability. Served as an integral member of the following teams to execute key organizational initiatives:- Technical Evaluation Committee to facilitate in-depth evaluation of applications for a competitive procurement that led to four new cooperative agreements in 2017;- ECT Short-term task teams for PrEP implementation/scale-up and transition to the fixed dose combination of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD).
Washington, Dc, Us
The AAAS S&T Policy Fellowship provides opportunities for outstanding scientists to participate in federal policymaking while contributing their knowledge and analytical skills to the executive branch of the federal government. • Received extensive training in science diplomacy, policy development and U.S. Government relations and functions, including preparation of reports and policy briefs for Congress. • Understanding of government and policymaking and prepared to develop and execute solutions to address societal challenges.
Training of staff of African national medicines regulatory agencies and pharmaceutical manufacturersin quality assurance and Advanced Good Manufacturing Practices at the USP Center in Accra. Notable Achievements: Trained 290 regulators and QA/QC personnel from 34 countries in three years Recipient of the 1st CePAT Award for Women in Global Health in 2014 in recognition of my contributions to the growth of the African pharmaceutical sector
• Conducted general assessment audits of manufacturers to evaluate compliance with WHO GMP in response to manufacturers expressions of interest for technical assistance. • Performed gap analysis after inspections and audits, generated reports on findings, identified and addressed the problems and issues• Provided technical and professional expertise to manufacturers in developing plans for corrective action and timelines to progress• Developed advanced and targeted courses and conducted training in GMP, Clinical Trials and Quality Control tailored to various target audiences e.g. regulatory inspectors vs manufacturers
Drove fund raising efforts for 501(c)(3) corporation to facilitate development of efficacious medicines from African medicinal plants for worldwide disease treatment.Notable Achievements:Successfully established public-private partnerships between two Ghana government entities in agricultural development and medical research as well as two private partners in research, development and manufacturing. These partnerships were essential in facilitating agricultural development of the plant, drug product development, and clinical trials of a novel anti-malarial from Cryptolepis sanguinolenta.
• Conceptualized the strategy and terms of reference for the twelve-member Expert Committee. • Identified and engaged the experts comprised of prominent pharmacists, attorneys and university professors of herbal medicine from anglophone, francophone and lusophone countries in ECOWAS. • Successfully steered the affairs of the committee, ensuring consensus of divergent views emanating from different disciplines, lineages, languages and legal environments • Organized, executed and led in-country training sessions, sponsored by the United Nations Development Programme and WAHO for personnel in ministries of Health, Justice and Trade & Industry in member-states on the newly developed TRIPs Policy, Guidelines & Legal Framework
Responsible for the day to day running of the company.Supervised the design, construction and implementation of Phase I and II of the LaGray project to establish the first fully integrated pharmaceutical manufacturing company in West Africa. First active pharmaceutical ingredient manufacturer in West Africa and second in Sub-Saharan Africa. - Effectively recruited, trained, and directed technical staff; groomed dozens of newly qualified graduates into supervisory and management positions. - Built the Quality Management System, ensuring all employees were actively involved in implementation and fully embraced the Quality Policy and principles. - Successfully led full range of functional and strategic units in compliance with international quality standards including: Quality Assurance, Regulatory Affairs, Production, Plant and Facilities, Finance, Production, and Business Development, earning the following recognitions:- 2009 Frost & Sullivan African Excellence Award for Innovation in the Pharmaceuticals Business- 2nd Ghana Business & Finance Excellence Award, Gold Category, 2010- 3rd Ghana Business & Finance Excellence Award, Gold Category, 2011- African Network for Drugs & Diagnostics Innovation, Center of Excellence for Drug Manufacturing - Led the development of a public-private partnership between GIZ, Sandoz and LaGray to improve access and quality of medicines in Ghana through manufacturing cooperation, distribution to rural areas, and training. - Spearheaded an innovative vocational training program, providing graduates in electronics, industrial mechanics, and electricals fields at the National Vocational Training Institute with specialized practical training in pharmaceutical manufacturing.
Geneva 27, Ge, Ch
• Served on an Expert Panel for UNDP/UNICEF/World Bank/WHO Special Programme for Research and Training in Neglected Tropical Diseases (TDR). • Evaluated applications for development of drugs against neglected diseases and inspected research facilities worldwide for their ability to conduct research for WHO-TDR
• Coordinated product analysis, manufacturing and distribution, starting from raw material vendor selection through production scheduling and worldwide distribution. • Designed methods for manufacturing and analyzing clinical drug candidates and proposed options to meet critical marketing needs. • Linked communication among customers, manufacturing sites, vendors, quality assurance, regulatory affairs and upper management.Notable Achievements:Efficiently managed a $1.5 billion annual pharmaceutical product portfolio of medicines that impacted millions of lives and designed effective methods for reducing costs on existing products.
Notable Achievements: Developed novel HPLC methodologies for the determination of gentamicin, analogs and degradation products in parenteral formulations. Developed novel physical methods for molecular weight characterization of iron-dextran complexes. Methods allowed for the development of analytical standards for manufacturing lots.
Chemistry lecturer.
Chemistry lecturer
Armonk, New York, Ny, Us
Research and development of photochemical polymers for micro-electronic applications.Notable AchievementsResearch resulted in two patent applications/IBM Inventor Recognition Awards
Research synthetic chemistry position under Prof. Iwao Ojima.
Chemistry laboratory instruction
Chemistry lecturer
Chemistry laboratory instruction
Chemistry laboratory instruction and tutorials
Quick answers generated from the profile data available on this page.
Dr. Alexandra E. Graham works for Avril Biopharma, Inc..
Dr. Alexandra E. Graham is listed as President @ LaGray | Innovator and Co-founder at Avril Biopharma, Inc..
AeroLeads has found 1 work email signal at @lagrayfinance.com for Dr. Alexandra E. Graham at Avril Biopharma, Inc..
AeroLeads has found 2 phone signal(s) with area code 773 for Dr. Alexandra E. Graham at Avril Biopharma, Inc..
Dr. Alexandra E. Graham is based in Chicago, Illinois, United States while working with Avril Biopharma, Inc..
Dr. Alexandra E. Graham has worked for Africa Ecogrowth Investment Services (Aegis), Avril Biopharma, Inc., Lagray, Inc., St. Karol School Of Nursing, and Lagray.
You can use AeroLeads to view verified contact signals for Dr. Alexandra E. Graham at Avril Biopharma, Inc., including work email, phone, and LinkedIn data when available.
Dr. Alexandra E. Graham holds Doctor Of Philosophy (Ph.D.), Organic Chemistry from University Of Lagos.
Dr. Alexandra E. Graham is listed with skills including Pharmaceutical Industry, Technology Transfer, Validation, Pharmaceutics, Strategy, Chemistry, Regulatory Affairs, and Project Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts